Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Translational Research and Innovation in Ophthalmology Vision - Centre of Excellence

Project description

Advancing vision care in Poland

Ophthalmic research has made significant progress in recent years, uncovering new insights into mechanisms behind eye diseases. However, over two billion people worldwide still suffer from vision problems, straining healthcare systems and daily life. New technologies including gene therapies, robotics and AI offer hope for better treatments and reduced costs, but challenges remain. To address these issues, the EU-funded TRIO-VI CoE project is launching the International Centre for Translational Eye Research (ICTER CoE) in Warsaw. This cutting-edge centre aims to improve patients’ quality of life by advancing knowledge and developing innovative ophthalmic technologies. Overall, it will enhance vision care and strengthen Poland's standing in the global field of vision research.

Objective

Eye diseases affect the daily lives of 2.2 billion people globally and have a significant socio-economic impact. However, recent advances have rapidly progressed our understanding of the mechanisms of ophthalmic diseases, opening unprecedented opportunities in the field of eye therapeutics. The development of new technologies (robotics, AI) and health services (virtual clinics) offers new solutions to improve the quality of life of ophthalmology patients and to reduce the costs and burdens for national healthcare systems. In the TRIO-VI project we address these challenges, focusing on translating the latest advances in science and technical research into practice in vision care. Together with strategic partners from UCL and Sorbonne, we create a centre of excellence – the International Center for Eye Research (ICTER CoE) in Warsaw, a sub-unit of the Institute of Physical Chemistry of the Polish Academy of Sciences. Unlocking scientific and translational potential of ICTER CoE guarantees tremendous impact on society, science, education and health by accelerating introduction of therapies and new solutions in vision care. It will boost the rapidly growing biophotonics and biomedical engineering industry in Poland by introducing new devices in ophthalmology.
As a result of TRIO-VI, we anticipate a considerable improvement in R&D&I capabilities in ICHF and ICTER, through enhanced education, training, and integrated skill development for all employee groups, with a focus on excellence, gender equality, and multidisciplinary collaboration. Thus, we aim to strengthen the R&I system in Poland, attract EU funding, increase visibility of Polish R&D institutions in EU and beyond, and substantially become a gamechanger for paradigm of ophthalmology in Central Europe. By boosting the changes ICTER CoE will become a lighthouse for the Polish Academy of Sciences, the largest research institute network in the country, and the scientific landscape in Poland and in the region.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-WIDERA-2023-ACCESS-01

See all projects funded under this call

Coordinator

INSTYTUT CHEMII FIZYCZNEJ POLSKIEJ AKADEMII NAUK
Net EU contribution
€ 9 000 000,00
Address
KASPRZAKA 44/52
01224 Warszawa
Poland
Region
Makroregion województwo mazowieckie Warszawski stołeczny Miasto Warszawa
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 9 000 000,00

Participants (5)